MSB 10.4% $1.49 mesoblast limited

Ann: Mesoblast Phase 3 Chronic Low Back Pain Results, page-595

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 1,254 Posts.
    lightbulb Created with Sketch. 1404
    @gan-Gans, your increasingly irrelevant comments and now almost hysterical down ramping in the face of excellent results totally convinces me MSB has the goods.
    What you wrote is in blatant defiance of the facts and is evidence of panic in the shorters' ranks. To quote you "they deserve to lose".

    Do you really think you fool anybody? You use language strongly critical of the CLBP results and yet do not offer even one word of scientific appraisal. The reason being, of course, that you have no ability to appraise them.

    "Trial flop"? "not clinically meaningful"? Go on, put up some facts. And include the opioid users' results to support the flop claim.
    Last edited by benelong: 12/02/21
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.